Adrenomedullin Restores Mitochondrial Bioenergetics and Rescues Interneuron Phenotypes in Human Models of 22q11.2 Deletion Syndrome
Dhriti NagariD, Jong Bin ChoiiD, Zunsong HuiD, Li LiiD, Madison S. HouseiD, Seyeon ParkiD, Bailey Abel, Anushka NikhiliD, Meghali AichiD, Saw HtuniD, Katja Gabriele WeinachtiD, Zhaohui GuiD, Anca M. PașcaiD
Abstract
22q11.2 deletion syndrome (22q11.2DS), also known as DiGeorge syndrome, is the strongest genetic risk factor for schizophrenia, yet the cellular mechanisms underlying this vulnerability remain incompletely understood. Using iPSC-derived human subpallial organoids (hSOs) and forebrain assembloids (hFAs), we identified key 22q11.2DS cellular and molecular phenotypes in migrating cortical interneurons and rescued them with Adrenomedullin (ADM), a 52-amino-acid peptide hormone that acts through the CLR/RAMP2 receptor complex. Specifically, we discover that 22q11.2DS interneurons exhibit impaired migration patterns, and that this is associated with excessive mitochondrial fragmentation, reduced oxidative phosphorylation, and dysregulated calcium signaling. Transcriptomic analysis reveals a glycolytic shift and widespread downregulation of oxidative phosphorylation genes. Next, we identify ADM as a potent rescue agent that restores mitochondrial morphology, membrane potential, respiration, calcium homeostasis, actin retrograde flow, and interneuron migration. Mechanistically, we find that ADM signals through two parallel pathways: PKA-mediated DRP1 Ser637 phosphorylation, which promotes mitochondrial fusion, and PLC-mediated calcium signaling, which normalizes actin dynamics. These phenotypes and their rescue are recapitulated in primary developing human cortical tissue carrying the 22q11.2 deletion. Overall, our study establishes a mitochondrial-cytoskeletal axis as a novel biological mechanism underlying the alterations observed in neuronal development in human preclinical models of 22q11.2DS and identifies possible therapeutic molecular targets for 22q11.2DS-associated neuropsychiatric pathology. HIGHLIGHTSO_LIInhibitory neurons in 22q11.2DS organoids and assembloids show mitochondrial fragmentation and impaired migration C_LIO_LIADM rescues mitochondrial morphology, respiration, and interneuron migration C_LIO_LIPKA and PLC pathways mediate separate arms of ADMs rescue mechanism C_LIO_LIPhenotypes and ADM rescue are validated in human cortical tissue C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synaptic microRNA dysregulation orchestrates aberrant glutamatergic transmission in a human neuronal model of 22q11.2 deletion syndrome
Weibo Niu, Jidong Guo, … Zhexing Wen·bioRxiv·Oct 15, 2026
- Systems Analysis of the 22q11.2 Microdeletion Syndrome Converges on a Mitochondrial Interactome Necessary for Synapse Function and Behavior
Avanti Gokhale, Cortnie L. Hartwig, … Victor Faúndez·Journal of NeurosciencePeer-reviewed·Jan 1, 2018
- Mitochondrial genes in the 22q11.2 deleted region regulate neural stem and progenitor cell proliferation
Philip D. Campbell, Isaiah Lee, … Michael Granato·bioRxiv·Jan 3, 2023
- Aberrant pace of cortical neuron development in brain organoids from patients with 22q11.2 deletion syndrome-associated schizophrenia
Sneha B. Rao, Zhixiong Sun, … Joseph A. Gogos·Nature CommunicationsPeer-reviewed·Aug 1, 2025
- Presenilin-deficient neurons and astrocytes display normal mitochondrial phenotypes
Sabrina Contino, Céline Vrancx, … Pascal Kienlen‐Campard·Frontiers in NeurosciencePeer-reviewed·Jan 22, 2021
- Neurovascular mitochondrial susceptibility impacts blood-brain barrier function and behavior
Alexis Mary Crockett, Hania Kébir, … Jorge Ivan Alvarez·bioRxiv·Feb 15, 2024